B&B Clinical Innovations Overview

  • Founded
  • 1976

  • Status
  • Acquired/​Merged

  • Employees
  • 130

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

B&B Clinical Innovations General Information


Provider of late-stage clinical development services to pharmaceutical and biotechnology industries. The company conducts clinical trials in the fields of allergies and asthma, cardiology, gastroenterology, HIV, infectious disease dermatology, metabolic studies, oncology, osteoporosis, and urology.

Contact Information

Formerly Known As
Berger Boyer & Associates
Ownership Status
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Primary Office
  • 2018 Baltimore Avenue
  • Kansas City, MO 64108
  • United States
+1 (816) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

B&B Clinical Innovations Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore B&B Clinical Innovations‘s full profile, request access.

Request a free trial

B&B Clinical Innovations Executive Team (5)

Name Title Board Seat Contact Info
Arthur Berger Founder & President
Ronald Wehmeyer Chief Financial Officer
Susan Cox Chief Operating Officer
You’re viewing 3 of 5 executive team members. Get the full list »

B&B Clinical Innovations Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial